The Food and Drug Administration (FDA) cautions patients who take Actos (pioglitazone) for their Type 2 diabetes that this powerful medication may increase the risk of heart failure. This cardiac risk is in addition to the well-documented rise in the incidence of bladder cancer for patients taking Actos for longer than one year.
As if the risks of Actos were not distressing enough, some patients received the drug without receiving a full disclosure of the risks related to this powerful drug product. The failure to sufficiently warn is possibility significant, influencing treatment strategies and eliminating meaningful patient and doctor choice.
Are you and your family interested in finding out more information about the danger of Actos and why the FDA has issued cautions about its potential heart failure and bladder risks. The attorneys at the Dallas law firm of Fears Nachawati are prepared to help you answer your important questions. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to give you the help you need.